vs

Side-by-side financial comparison of Emerson Electric (EMR) and Prologis (PLD). Click either name above to swap in a different company.

Emerson Electric is the larger business by last-quarter revenue ($4.3B vs $2.3B, roughly 1.9× Prologis). Prologis runs the higher net margin — 62.1% vs 13.9%, a 48.2% gap on every dollar of revenue. On growth, Emerson Electric posted the faster year-over-year revenue change (4.1% vs 2.4%). Over the past eight quarters, Prologis's revenue compounded faster (7.3% CAGR vs -0.3%).

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

Prologis, Inc. is a real estate investment trust headquartered in San Francisco, California that invests in logistics facilities. The company was formed through the merger of AMB Property Corporation and Prologis in June 2011, which made Prologis the largest industrial real estate company in the world. As of 2025, the company operates more than 15,000 land acres and over 6,000 buildings comprising about 1.

EMR vs PLD — Head-to-Head

Bigger by revenue
EMR
EMR
1.9× larger
EMR
$4.3B
$2.3B
PLD
Growing faster (revenue YoY)
EMR
EMR
+1.7% gap
EMR
4.1%
2.4%
PLD
Higher net margin
PLD
PLD
48.2% more per $
PLD
62.1%
13.9%
EMR
Faster 2-yr revenue CAGR
PLD
PLD
Annualised
PLD
7.3%
-0.3%
EMR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
EMR
EMR
PLD
PLD
Revenue
$4.3B
$2.3B
Net Profit
$605.0M
$1.4B
Gross Margin
53.2%
Operating Margin
17.8%
72.2%
Net Margin
13.9%
62.1%
Revenue YoY
4.1%
2.4%
Net Profit YoY
3.4%
9.5%
EPS (diluted)
$1.07
$1.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EMR
EMR
PLD
PLD
Q4 25
$4.3B
$2.3B
Q3 25
$4.9B
$2.2B
Q2 25
$4.6B
$2.2B
Q1 25
$4.4B
$2.1B
Q4 24
$4.2B
$2.2B
Q3 24
$4.6B
$2.0B
Q2 24
$4.4B
$2.0B
Q1 24
$4.4B
$2.0B
Net Profit
EMR
EMR
PLD
PLD
Q4 25
$605.0M
$1.4B
Q3 25
$637.0M
$764.3M
Q2 25
$586.0M
$571.2M
Q1 25
$485.0M
$593.0M
Q4 24
$585.0M
$1.3B
Q3 24
$996.0M
$1.0B
Q2 24
$329.0M
$861.3M
Q1 24
$501.0M
$585.7M
Gross Margin
EMR
EMR
PLD
PLD
Q4 25
53.2%
Q3 25
51.9%
Q2 25
52.6%
Q1 25
53.5%
Q4 24
53.5%
Q3 24
51.3%
Q2 24
52.8%
Q1 24
52.2%
Operating Margin
EMR
EMR
PLD
PLD
Q4 25
17.8%
72.2%
Q3 25
16.4%
42.5%
Q2 25
16.1%
41.8%
Q1 25
14.2%
41.1%
Q4 24
18.6%
64.6%
Q3 24
14.7%
61.4%
Q2 24
10.4%
51.0%
Q1 24
16.2%
36.8%
Net Margin
EMR
EMR
PLD
PLD
Q4 25
13.9%
62.1%
Q3 25
13.1%
34.5%
Q2 25
12.9%
26.2%
Q1 25
10.9%
27.7%
Q4 24
14.0%
58.1%
Q3 24
21.6%
49.4%
Q2 24
7.5%
42.9%
Q1 24
11.4%
29.9%
EPS (diluted)
EMR
EMR
PLD
PLD
Q4 25
$1.07
$1.50
Q3 25
$1.12
$0.82
Q2 25
$1.04
$0.61
Q1 25
$0.86
$0.63
Q4 24
$1.02
$1.38
Q3 24
$1.74
$1.08
Q2 24
$0.57
$0.92
Q1 24
$0.87
$0.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EMR
EMR
PLD
PLD
Cash + ST InvestmentsLiquidity on hand
$1.1B
Total DebtLower is stronger
$7.6B
$35.0B
Stockholders' EquityBook value
$20.3B
$53.2B
Total Assets
$41.9B
$98.7B
Debt / EquityLower = less leverage
0.37×
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EMR
EMR
PLD
PLD
Q4 25
$1.1B
Q3 25
$1.2B
Q2 25
$1.1B
Q1 25
$671.1M
Q4 24
$1.3B
Q3 24
$780.9M
Q2 24
$598.3M
Q1 24
$500.6M
Total Debt
EMR
EMR
PLD
PLD
Q4 25
$7.6B
$35.0B
Q3 25
$8.9B
$35.3B
Q2 25
$8.3B
$34.7B
Q1 25
$8.2B
$32.3B
Q4 24
$6.6B
$30.9B
Q3 24
$7.7B
$32.3B
Q2 24
$7.1B
$29.9B
Q1 24
$7.6B
$29.6B
Stockholders' Equity
EMR
EMR
PLD
PLD
Q4 25
$20.3B
$53.2B
Q3 25
$20.3B
$52.6B
Q2 25
$19.9B
$52.7B
Q1 25
$19.2B
$53.5B
Q4 24
$20.5B
$54.0B
Q3 24
$21.6B
$53.1B
Q2 24
$20.8B
$53.3B
Q1 24
$20.9B
$53.2B
Total Assets
EMR
EMR
PLD
PLD
Q4 25
$41.9B
$98.7B
Q3 25
$42.0B
$98.3B
Q2 25
$42.5B
$97.7B
Q1 25
$42.0B
$96.0B
Q4 24
$42.6B
$95.3B
Q3 24
$44.2B
$95.9B
Q2 24
$45.6B
$93.5B
Q1 24
$46.4B
$93.3B
Debt / Equity
EMR
EMR
PLD
PLD
Q4 25
0.37×
0.66×
Q3 25
0.44×
0.67×
Q2 25
0.42×
0.66×
Q1 25
0.42×
0.60×
Q4 24
0.32×
0.57×
Q3 24
0.36×
0.61×
Q2 24
0.34×
0.56×
Q1 24
0.36×
0.56×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EMR
EMR
PLD
PLD
Operating Cash FlowLast quarter
$699.0M
$1.2B
Free Cash FlowOCF − Capex
$602.0M
FCF MarginFCF / Revenue
13.9%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
1.16×
0.83×
TTM Free Cash FlowTrailing 4 quarters
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EMR
EMR
PLD
PLD
Q4 25
$699.0M
$1.2B
Q3 25
$3.1B
$1.4B
Q2 25
$1.1B
$1.2B
Q1 25
$241.0M
$1.2B
Q4 24
$777.0M
$1.3B
Q3 24
$3.3B
$1.4B
Q2 24
$1.1B
$1.1B
Q1 24
$743.0M
$1.1B
Free Cash Flow
EMR
EMR
PLD
PLD
Q4 25
$602.0M
Q3 25
$2.7B
Q2 25
$977.0M
Q1 25
$154.0M
Q4 24
$694.0M
Q3 24
$2.9B
Q2 24
$998.0M
Q1 24
$661.0M
FCF Margin
EMR
EMR
PLD
PLD
Q4 25
13.9%
Q3 25
54.9%
Q2 25
21.5%
Q1 25
3.5%
Q4 24
16.6%
Q3 24
63.1%
Q2 24
22.8%
Q1 24
15.1%
Capex Intensity
EMR
EMR
PLD
PLD
Q4 25
2.2%
Q3 25
8.9%
Q2 25
2.0%
Q1 25
2.0%
Q4 24
2.0%
Q3 24
9.1%
Q2 24
2.1%
Q1 24
1.9%
Cash Conversion
EMR
EMR
PLD
PLD
Q4 25
1.16×
0.83×
Q3 25
4.86×
1.89×
Q2 25
1.83×
2.17×
Q1 25
0.50×
1.96×
Q4 24
1.33×
1.04×
Q3 24
3.35×
1.43×
Q2 24
3.31×
1.26×
Q1 24
1.48×
1.80×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

PLD
PLD

Real Estate Operations Segment$2.0B88%
Unconsolidated Co Investment Ventures$131.7M6%
Other$82.6M4%
Strategic Capital Segment$49.9M2%

Related Comparisons